These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 38926085)

  • 1. Transgenic Targeting of
    Kaiser T; Dattero J; Li L; Chen M; Jiang M; Harrahill A; Butovsky O; Feng G
    eNeuro; 2024 Jul; 11(7):. PubMed ID: 38926085
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tmem119-EGFP and Tmem119-CreERT2 Transgenic Mice for Labeling and Manipulating Microglia.
    Kaiser T; Feng G
    eNeuro; 2019; 6(4):. PubMed ID: 31371457
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Human CD68 Promoter-Driven Inducible Cre-Recombinase Mouse Line Allows Specific Targeting of Tissue Resident Macrophages.
    Rumianek AN; Davies B; Channon KM; Greaves DR; Purvis GSD
    Front Immunol; 2022; 13():918636. PubMed ID: 35874787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identifying the variables that drive tamoxifen-independent CreERT2 recombination: Implications for microglial fate mapping and gene deletions.
    Van Hove H; Antunes ARP; De Vlaminck K; Scheyltjens I; Van Ginderachter JA; Movahedi K
    Eur J Immunol; 2020 Mar; 50(3):459-463. PubMed ID: 31785096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal control of gene recombination in astrocytes by transgenic expression of the tamoxifen-inducible DNA recombinase variant CreERT2.
    Hirrlinger PG; Scheller A; Braun C; Hirrlinger J; Kirchhoff F
    Glia; 2006 Jul; 54(1):11-20. PubMed ID: 16575885
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Cre-deleter specific for embryo-derived brain macrophages reveals distinct features of microglia and border macrophages.
    Brioschi S; Belk JA; Peng V; Molgora M; Rodrigues PF; Nguyen KM; Wang S; Du S; Wang WL; Grajales-Reyes GE; Ponce JM; Yuede CM; Li Q; Baer JM; DeNardo DG; Gilfillan S; Cella M; Satpathy AT; Colonna M
    Immunity; 2023 May; 56(5):1027-1045.e8. PubMed ID: 36791722
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cre-mediated recombination efficiency and transgene expression patterns of three retinal bipolar cell-expressing Cre transgenic mouse lines.
    Lu Q; Ivanova E; Ganjawala TH; Pan ZH
    Mol Vis; 2013; 19():1310-20. PubMed ID: 23805038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting Microglia Using Cx3cr1-Cre Lines: Revisiting the Specificity.
    Zhao XF; Alam MM; Liao Y; Huang T; Mathur R; Zhu X; Huang Y
    eNeuro; 2019; 6(4):. PubMed ID: 31201215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CatacLysMic specificity when targeting myeloid cells?
    Blank T; Prinz M
    Eur J Immunol; 2016 Jun; 46(6):1340-2. PubMed ID: 27198084
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of endothelial promoter efficiency and specificity in mice reveals a subset of Pdgfb-positive hematopoietic cells.
    Kilani B; Gourdou-Latyszenok V; Guy A; Bats ML; Peghaire C; Parrens M; Renault MA; Duplàa C; Villeval JL; Rautou PE; Couffinhal T; James C
    J Thromb Haemost; 2019 May; 17(5):827-840. PubMed ID: 30801958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gcg
    Shiota C; Prasadan K; Guo P; Fusco J; Xiao X; Gittes GK
    Diabetologia; 2017 Dec; 60(12):2399-2408. PubMed ID: 28884202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A comparative analysis of microglial inducible Cre lines.
    Faust TE; Feinberg PA; O'Connor C; Kawaguchi R; Chan A; Strasburger H; Frosch M; Boyle MA; Masuda T; Amann L; Knobeloch KP; Prinz M; Schaefer A; Schafer DP
    Cell Rep; 2023 Sep; 42(9):113031. PubMed ID: 37635351
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of LysM-cre and Cdh5-cre Driver Mice in Retinal and Brain Research: An Imaging Study Using tdTomato Reporter Mouse.
    Fouda AY; Xu Z; Narayanan SP; Caldwell RW; Caldwell RB
    Invest Ophthalmol Vis Sci; 2020 Mar; 61(3):51. PubMed ID: 32232350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Establishment of a tamoxifen-inducible Cre-driver mouse strain for widespread and temporal genetic modification in adult mice.
    Ichise H; Hori A; Shiozawa S; Kondo S; Kanegae Y; Saito I; Ichise T; Yoshida N
    Exp Anim; 2016 Jul; 65(3):231-44. PubMed ID: 26923756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inducible gene manipulations in brain serotonergic neurons of transgenic rats.
    Weber T; Schönig K; Tews B; Bartsch D
    PLoS One; 2011; 6(11):e28283. PubMed ID: 22140568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A mouse model with tamoxifen-inducible thyrocyte-specific cre recombinase activity.
    Undeutsch H; Löf C; Offermanns S; Kero J
    Genesis; 2014 Apr; 52(4):333-40. PubMed ID: 24395757
    [TBL] [Abstract][Full Text] [Related]  

  • 17. VE-cadherin-CreERT2 transgenic mouse: a model for inducible recombination in the endothelium.
    Monvoisin A; Alva JA; Hofmann JJ; Zovein AC; Lane TF; Iruela-Arispe ML
    Dev Dyn; 2006 Dec; 235(12):3413-22. PubMed ID: 17072878
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tamoxifen-inducible glia-specific Cre mice for somatic mutagenesis in oligodendrocytes and Schwann cells.
    Leone DP; Genoud S; Atanasoski S; Grausenburger R; Berger P; Metzger D; Macklin WB; Chambon P; Suter U
    Mol Cell Neurosci; 2003 Apr; 22(4):430-40. PubMed ID: 12727441
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential oocyte-specific expression of Cre recombinase activity in GDF-9-iCre, Zp3cre, and Msx2Cre transgenic mice.
    Lan ZJ; Xu X; Cooney AJ
    Biol Reprod; 2004 Nov; 71(5):1469-74. PubMed ID: 15215191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tamoxifen-independent recombination of reporter genes limits lineage tracing and mosaic analysis using CreER
    Álvarez-Aznar A; Martínez-Corral I; Daubel N; Betsholtz C; Mäkinen T; Gaengel K
    Transgenic Res; 2020 Feb; 29(1):53-68. PubMed ID: 31641921
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.